Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-37,000
Closed -$1.14M 296
2016
Q4
$1.14M Buy
+37,000
New +$1.14M 0.05% 134
2016
Q2
Sell
-53,500
Closed -$19.3M 281
2016
Q1
$19.3M Sell
53,500
-6,000
-10% -$147K 0.73% 26
2015
Q4
$1.68M Buy
59,500
+34,500
+138% +$995K 0.12% 128
2015
Q3
$696K Buy
+25,000
New +$903K 0.04% 159
2015
Q2
Sell
-30,000
Closed -$1K 514
2015
Q1
$1K Sell
30,000
-130,500
-81% -$3.38M ﹤0.01% 391
2014
Q4
$4K Buy
+160,500
New +$3.59M ﹤0.01% 202
2013
Q4
Sell
-70,000
Closed -$776K 259
2013
Q3
$776K Hold
70,000
0.11% 117
2013
Q2
$577K Buy
+70,000
New +$588K 0.06% 150

Other funds holding RGEN

Cowen Inc's RGEN Position: Q4 2014 in Review

Cowen Inc sold out of Repligen (RGEN) in Q4 2014, closing a stake of 3,000 shares — an estimated $67.1K sold.

Cowen Inc first reported a position in RGEN in Q3 2014 and held it in 1 quarter. The position peaked at $60K in Q3 2014. 164 funds tracked by Wall St. Rank hold RGEN as of Q4 2014.

  • Cowen Inc reported no remaining Repligen position as of Q4 2014 after selling out during the quarter.
  • Cowen Inc sold 3,000 Repligen shares in Q4 2014, an estimated $67.1K.
  • Cowen Inc first reported a position in Repligen in Q3 2014 and held it in 1 quarter.
  • Cowen Inc's Repligen position peaked at $60K in Q3 2014.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q4 2014.

Based on Cowen Inc's 13F filing for Q4 2014, filed 17 Feb 2015.